IPSC vs XFOR: stock comparison and AI forecast
Century Therapeutics, Inc. (IPSC) and X4 Pharmaceuticals, Inc (XFOR) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
IPSC Century Therapeutics, Inc.
- Price
- $1.68 -27.3% · 6M
- Market Cap
- $304M
- P/E Ratio
- 24.0x
- Size
- small-cap
- AI Forecast
XFOR X4 Pharmaceuticals, Inc
- Market Cap
- $315M
- P/E Ratio
- 1.5x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- IPSC and XFOR have similar market capitalizations ($304M and $315M).
- XFOR trades at 1.5 times trailing earnings, IPSC at 24.0 times.
- XFOR carries 0.67 times debt per unit of equity, against 0.24 times for IPSC.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | IPSC | XFOR |
|---|---|---|
| Market Cap | $304M | $315M |
| P/E Ratio | 24.00x | 1.49x |
| P/B Ratio | 1.31x | 2.27x |
| EPS | $0.07 | $2.13 |
| Book Value/Share | $1.28 | $1.40 |
| Revenue/Share | – | $0.10 |
| FCF/Share | $-0.49 | – |
Profitability & Margins
| Metric | IPSC | XFOR |
|---|---|---|
| ROIC | -43.0% | -37.1% |
| Gross Margin | – | 88.0% |
| Operating Margin | 53.6% | -812.8% |
| EBT Margin | 41.3% | -810.9% |
| Tax Rate | -1.9% | -0.0% |
Financial Health
| Metric | IPSC | XFOR |
|---|---|---|
| Current Ratio | 8.28x | 13.22x |
| Quick Ratio | – | 13.21x |
| D/E Ratio | 0.24x | 0.67x |
| Financial Leverage | 1.24x | 1.67x |
| Interest Coverage | -257.9x | -2.9x |
| Working Capital | $110M | $183M |
Cash Flow
| Metric | IPSC | XFOR |
|---|---|---|
| Operating Cash Flow | -$87M | -$76M |
| Free Cash Flow | -$88M | – |
| Capital Spending | -$1M | – |
Operational Efficiency
| Metric | IPSC | XFOR |
|---|---|---|
| Asset Turnover | – | 0.04x |
| Receivables Turnover | – | 6.7x |
| Inventory Turnover | – | 12.1x |
| Fixed Assets Turnover | – | 173.5x |
| Days Sales Outstanding | – | 54 days |
| Days Inventory | – | 30 days |
| Payables Period | – | 577 days |
| Cash Conversion Cycle | – | -492 days |
Income Statement
| Metric | IPSC | XFOR |
|---|---|---|
| Total Revenue | – | $10M |
| Operating Income | -$117M | -$80M |
| R&D Expense | $79M | $62M |
| Cost of Goods Sold | – | $3M |
Dividend & Shareholder Information
| Metric | IPSC | XFOR |
|---|---|---|
| Shares Outstanding | 181M | 99M |
IPSC vs XFOR: stock comparison and AI forecast
Which is bigger, IPSC or XFOR?
IPSC and XFOR have similar market capitalizations ($304M and $315M).
Which is cheaper on earnings, IPSC or XFOR?
XFOR trades at 1.5 times trailing earnings, IPSC at 24.0 times.
Which one does Intratio's AI model rank higher, IPSC or XFOR?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.